Yamamoto T, Patel M V, Park J H. "一种的合成方法" [P]. US Patent, US 10795107 B2, 2017-01-26.
发明人郑宇鹏,冯建国,周伟. "Method for the Synthesis of 4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]aniline" [P]. 中国发明专利, 专利号 CN 116230085 A, 授权公告日 2020-10-06.
Park J H, Chen K W, Williams B T. "A Process for Preparing High-Purity 4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]aniline" [P]. US Patent, US 9357984 B2, 2020-02-13.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2016, 2229, (2), 9685-9700.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2025, 1965, (4), 418-430.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]aniline Using HRMS and NMR". Molecules, 2020, 2148, (2), 5448-5452.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2011, 107, 1863-1885.